Essais liés10clinical trials
VilleJinanlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07732309

Ouvrir le site du centre

Essais cliniques associés

10
MoléculeIndication / populationPhaseNCTTitreStatut
Rimegepant Migraine Phase 3 NCT05810038 A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. COMPLETED
Clemizole HCl Épilepsie Phase 3 NCT05066217 An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome RECRUITING
Skeletal muscle biopsy (residual specimen) Myopathies À vérifier NCT06101940 Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1) ENROLLING_BY_INVITATION
Vagus Nerve Stimulation in early stage SEP Phase 1 NCT06938243 Wether VNS in Early Stage (3 Months) is Safe and More Beneficial for Post-stroke Motor Rehabilitation RECRUITING
ATG-201 Lupus Phase 1 NCT07732309 ATTRACT — A Study of ATG-201 in Adult Participants With Autoimmune Diseases NOT_YET_RECRUITING
Telitacicept Myasthénie Phase 3 NCT06456580 A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) RECRUITING
Nipocalimab Myasthénie Phase 3 NCT04951622 A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis RECRUITING
Litifilimab Lupus Phase 2/3 NCT05531565 AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus ACTIVE_NOT_RECRUITING
Telitacicept Lupus Phase 1 NCT05247203 Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus COMPLETED
Efgartigimod PH20 SC Myasthénie Phase 3 NCT06558279 ADAPT oculus — A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis ACTIVE_NOT_RECRUITING